Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director
CC transcript

ROCKWELL MEDICAL, INC. (RMTI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Investor presentation, Quarterly results
Docs: "Rockwell Medical Announces Second Quarter 2023 Results"
07/11/2023 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Unregistered Sales of Equity Secur...
05/23/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/15/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
05/15/2023 8-K Investor presentation, Quarterly results
Docs: "Rockwell Medical Announces First Quarter 2023 Results"
04/13/2023 8-K Quarterly results
03/30/2023 8-K Quarterly results
11/14/2022 8-K Investor presentation
Docs: "Rockwell Medical Provides Business Strategy Update and Announces Third Quarter 2022 Financial and Operational Results"
08/15/2022 8-K Quarterly results
06/22/2022 8-K Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce...
Docs: "Rockwell Medical, Inc. Appoints Mark Strobeck, Ph.D., as President and Chief Executive Officer"
06/13/2022 8-K Quarterly results
06/02/2022 8-K Quarterly results
05/20/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
05/13/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
04/08/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "ROCKWELL MEDICAL, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES X CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW ROCKWELL MEDICAL, INC., a Delaware corporation , in accordance with the provisions of Section 103 of the Delaware General Corporation Law does hereby certify that, in accordance with Sections 141 and 151 of the DGCL, the following resolution was duly adopted by a committee of the Board of Directors of the Corporation acting upon authority delegated by the Board of Directors, on April 6, 2022: RESOLVED, pursuant to authority expressly set forth in the Amended and Restated Certificate of Incorporation of the Corporation, as amended , the issuance of a series of Preferred Stock designated as the Series ..."
03/21/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/18/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/05/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "ROCKWELL MEDICAL, INC. TRANSFORMING IRON DEFICIENCY AND ANEMIA MANAGEMENT"
12/14/2021 8-K Quarterly results
12/10/2021 8-K Quarterly results
11/15/2021 8-K Investor presentation
Docs: "Rockwell Medical, Inc. Provides Third Quarter 2021 Financial and Operational Update - Third quarter net sales of $16.0 Million, up 6% sequential quarter-over-quarter and 5% year-over-year -"
09/30/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT THIS FIRST AMENDMENT to Loan and Security Agreement is entered into as of September 24, 2021 by and among INNOVATUS LIFE SCIENCES LENDING FUND I, LP, a Delaware limited partnership, as collateral agent , and the Lenders listed on Schedule 1.1 hereof or otherwise a party hereto from time to time, and ROCKWELL MEDICAL, INC., a Delaware corporation and ROCKWELL TRANSPORTATION, INC., a Michigan corporation and a wholly owned Subsidiary of Parent . WHEREAS, Collateral Agent, Borrower and Lenders have entered into that certain Loan and Security Agreement, dated as of March 16, 2020 pursuant to which Lenders have provided to Borrower certain loans in accordance with the terms and conditions thereof; and WHEREAS, Borrower, Lenders and Collateral Agent..."
08/16/2021 8-K Investor presentation
Docs: "Rockwell Medical, Inc. Provides Second Quarter 2021 Financial and Operational Update -Entered into exclusive license agreement with Drogsan Pharmaceuticals for the rights to commercialize Triferic® in Turkey-"
06/21/2021 8-K Quarterly results
06/17/2021 8-K Quarterly results
05/17/2021 8-K Quarterly results
03/31/2021 8-K Quarterly results
01/25/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/15/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/09/2020 8-K Investor presentation
Docs: "-Q3 2020 revenue of $15.3 million- -U.S. commercial launch of Triferic® AVNU expected in Q1 2021- -Poised to enroll first patient in Phase 3 clinical trial of Triferic in China- -Unveiled plans to develop FPC platform in new indications-"
11/05/2020 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "AMENDED & RESTATED BYLAWS OF"
09/25/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy